APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneOperatingExpenses01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:FourOperatingExpenses01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentRevenue01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentRevenue02Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:FourReportableSegmentRevenue01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:FourReportableSegmentRevenue02Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentResults01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentResults02Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:FourReportableSegmentResults01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:FourReportableSegmentResults02Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentAssets01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentAssets02Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2018-12-31in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2018-10-012018-12-31in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2018-12-31in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares APOLLOHOSP 2018-04-01 2019-03-31 2019-01-17 INR Lakhs Third quarter Multi segment 2018-10-01 2018-12-31 Unaudited Standalone 21690400000.00 81100000.00 21771500000.00 3574700000.00 7799400000.00 -45100000.00 3404800000.00 690000000.00 765700000.00 4278000000.00 20467500000.00 1304000000.00 0.00 1304000000.00 285100000.00 149600000.00 434700000.00 0.00 869300000.00 0.00 0.00 0.00 0.00 869300000.00 -40800000.00 828500000.00 828500000.00 0.00 695600000.00 5 6.25 6.25 0.00 0.00 6.25 6.25 NOTES: n n1.tThe unaudited financial results for the three months and nine months ended December 31, 2018 have been reviewed by the Audit Committee and approved by the Board of Directors in their meetings held on February 8, 2019 and February 9, 2019 respectively and have been subjected to limited review by the statutory auditors. n n2.tThe listed non-convertible debentures of the Company aggregating to Rs. 70,000 lakhs as on 31st December 2018 are secured by way of pari-passu first charge on the fixed assets of the Company existing and future along with Banks and Institutions and the asset cover thereof exceeds hundred percent of the principal amount of the said debentures. n n3.tThe Board of Directors at their meeting held on November 14, 2018 have approved a Scheme of Arrangement (“the Scheme”) between Apollo Hospitals Enterprise Limited (“AHEL”) and Apollo Pharmacies Limited (“APL”)and their respective shareholders in accordance with the provisions of Sections 230 to 232 of the Companies Act, 2013, for the transfer of the front-end retail pharmacy business carried out in the standalone pharmacy segment to APL by way of slump sale, subject to necessary approvals by stock exchanges, shareholders, National Company Law Tribunal and all other requisite regulatory authorities. Pending receipt of necessary approvals, no effect for the Scheme has been given in the results for the three and nine months ended December 31, 2018. n4.tEffective April 1, 2018 the Company has adopted IND AS 115 – Revenue from contracts with customers, using the cumulative catch-up transition method which is applied to contracts that were not completed as of April 1, 2018. Accordingly, the comparatives have not been retrospectively adjusted. The effect of adoption of IND AS 115 is insignificant. n n5.tOther Income includes the following nParticularstThree months ended 31/12/2018tThree months ended 30/09/2018tCorresponding Three months ended n 31/12/2017tYear to date figures for year ended 31/12/2018tYear to date figures for previous year ended 31/12/2017tPrevious year ended 31/03/2018 nNet exchange (gain) / losst-301 n-t271t-226t-27t324t168 n 2018-04-01 2018-12-31 Unaudited Standalone 61695500000.00 100900000.00 61796400000.00 10370800000.00 22875100000.00 -817700000.00 9477300000.00 1970900000.00 2228500000.00 12266700000.00 58371600000.00 3424800000.00 0.00 3424800000.00 825500000.00 338400000.00 1163900000.00 0.00 2260900000.00 0.00 0.00 0.00 0.00 2260900000.00 -237100000.00 2023800000.00 2023800000.00 0.00 695600000.00 5 16.25 16.25 0.00 0.00 16.25 16.25 Other Expenses 4278000000.00 Other Expenses 12266700000.00 healthcare services 11573300000.00 pharmacy 10118900000.00 healthcare services 33024800000.00 pharmacy 28676700000.00 21692200000.00 61701500000.00 1800000.00 6000000.00 21690400000.00 61695500000.00 healthcare services 1452400000.00 pharmacy 460500000.00 healthcare services 4081000000.00 pharmacy 1213800000.00 1912900000.00 5294800000.00 690000000.00 1970900000.00 81100000.00 100900000.00 1141800000.00 3223000000.00 healthcare services 60197000000.00 pharmacy 11179400000.00 71376400000.00 12924100000.00 84300500000.00 healthcare services 8163100000.00 pharmacy 2444500000.00 10607600000.00 35571700000.00 46179300000.00